6) suppresses cell growth in colon cancer [43]; downregulates HOXA9, playing a role in the development of many organs and often upregulated in myeloid leukemias [37]; regulates angiogenic signaling and vascular integrity [38]; overexpressed in ALL and AML [42]. Here, HOXA9 is linked to colonic neoplasm.